Document:

Exhibit 10.5

 

 

EMPLOYMENT AGREEMENT

 

THIS AGREEMENT, made
effective August 1, 2016 (the "Effective Date"), between AVRA Medical Robotics Inc., a Florida corporation (hereinafter
referred to as the "Company"), and Albert Christian Schauer, residing at 6455 N 39th Street, Augusta, Michigan 49012,
USA (hereinafter referred to as the "Employee").

 

WHEREAS, the Company
wishes to engage the services and expertise of the Employee on the terms and conditions hereinafter set forth, and the Employee
wishes to accept such an engagement;

 

NOW THEREFORE in
consideration of the covenants of each of the parties given to the other and for other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

		1.	SERVICES

 

Effective as of the Effective
Date, the Company hereby engages the Employee and the Employee hereby accepts an engagement with the Company to serve as the Chief
Financial Officer of the Company (the “Services”). Employee shall bear such responsibilities as are customary for such
a position in a public company. The parties understand that the position will be full-time employment and that the Employee shall
devote sufficient time, attention and abilities to the business of the Company for the proper exercise of the Employee's duties
hereunder. Employee understands that the Services may, from time to time, entail extensive travel. Employee may assign the compensation
hereunder but not the responsibility to fulfill the services and responsibilities as per this Agreement. Employee shall not be
required to move his residence.

 

		2.	REMUNERATION

 

The Company agrees to pay the Employee as set
out in Schedule A attached hereto.

 

		3.	CONFIDENTIALITY; OWNERSHIP OF DOCUMENTS; NON-COMPETE

 

3.1 Confidential Information. Employee
recognizes and acknowledges that by reason of this Agreement and service to the Company, he will have access to confidential information
of the Company and its affiliates, including, without limitation, information and knowledge pertaining to business methods, inventions,
innovations, designs, ideas, plans, trade secrets, proprietary information, advertising, sales and profit figures, contact lists,
and relationships between the Company and its affiliates, customers, clients, Employees, licensees, suppliers, and others who have
business dealings with the Company and its affiliates (“Confidential Information”). Employee acknowledges that such
Confidential Information is a valuable and unique asset and covenants that he will not, either during or at any time after the
Term of this Agreement, disclose any such Confidential Information to any person for any reason whatsoever without the prior written
authorization of the Company, unless such information is in the public domain through no fault of the Employee or except as, and
to the extent as, may be required by law.

 

     

     

    

 

3.2 Non-Competition

 

a. Employee recognizes that in his position
as an Employee to the Company, he will acquire such information outlined in Section 3.1 hereof, and for good and valuable consideration,
including his engagement by the Company, he agrees that during the Term of this Agreement and for a period of 12 months after
termination of this Agreement, Employee will not, unless acting pursuant hereto or with the prior written consent of the Company,
directly or indirectly, manage, operate, join, control, or participate in the management, operation, control, or be connected
as an officer, director, employee, partner, principal, agent, representative, Employee, or otherwise with or use or permit his
name to be used in connection with, any business or enterprise engaged in the primary line of business in which the Company is
engaged in at the time of execution of this Agreement.

 

b. The foregoing restriction
shall not be construed to prohibit the ownership by the Employee of more than five percent (5%) of any class of securities of any
corporation that is engaged in any of the foregoing businesses having a class of securities registered pursuant to the Securities
Exchange Act of 1934, provided that such ownership represents a passive investment and that neither the Employee nor any group
of persons including the Employee in any way, either directly or indirectly, manages or exercises control of any such corporation,
guarantees any of its financial obligations, otherwise takes any part in its business, other than exercising his rights as a shareholder,
or seeks to do any of the foregoing.

 

3.3 Non-solicitation; Non-association.
The Employee hereby acknowledges and agrees that he, together with other Employees engaged by the Company, is likely to be exposed
to a significant amount of Confidential Information concerning the Company’s, business methods, operations, employment relationships,
and customers while engaged under this Agreement, that such information might be retained by the Employee and such other Employees
in tangible form or simply retained in their memory, and that the protection of the Company’s exclusive rights to such confidential
information and the benefits flowing from it can best be ensured by means of a restriction on the Employee’s activities after
termination of this Agreement. Therefore, the Employee agrees that for 12 months period following termination of this Agreement,
he shall not engage in the following activities:

 

(a) He shall not solicit,
divert, or initiate any contact (or attempt to solicit, divert, or initiate any contact) with any relationship of the Company
or any affiliate with whom Employee dealt (including any customers or vendors), for the purpose of doing business in the same
lines of business as the Company, and further will not solicit or initiate any contact with any potential relationship of the
Company or affiliate, that the Employee solicited or contacted while engaged by the Company. This provision does not restrict
Employee from developing relationships independently obtained outside of Employee’s position with the Company.

 

    	 	- 2 -	 

     

    

 

(b) He shall not directly
solicit the employment of or hire any employee or Employee of the Company or affiliate and will not attempt to persuade any employee
or Employee to leave the employment or consulting relationship of the Company or such affiliate.

 

3.4 Equitable Relief.

 

(a)      Employee acknowledges that the restrictions
contained in Article 3 hereof are reasonable and necessary to protect the legitimate interests of the Company and that any violation
of such restrictions would result in irreparable injury to the Company. If the period of time or other restrictions specified in
Article 3 should be adjudged unreasonable at any proceeding, then the period of time or such other restrictions shall be reduced
by the elimination or reduction of such portion thereof so that such restrictions may be enforced in a manner adjudged to be reasonable.
Employee acknowledges that the Company shall be entitled to preliminary and permanent injunctive relief for a violation of any
such restrictions without having to prove actual damages or to post a bond; Company shall also be entitled to an equitable accounting
of all earnings, profits and other benefits arising from such violation, which rights shall be cumulative and in addition to any
other rights or remedies to which Company may be entitled in law or equity.

 

(b)      Employee agrees that until the expiration
of the covenants contained in Sections 3.2 and 3.3 of this Agreement, the Company may provide a copy of the covenant contained
in such Sections to any business or enterprise (i) that Employee may directly or indirectly own, manage, operate, finance, join,
control, or participate in the ownership, management, operation, financing, control, or control of, or (ii) with which he may be
connected as an officer, director, employee, partner, principal, agent, representative, Employee, or otherwise, or in connection
with which he may use or permit his name to be used.

 

		4.	TERM and TERMINATION

 

4.1    The term of this Agreement shall continue
for 12 months from the Effective Date and may be renewed thereafter annually by mutual written consent (“Term”). Upon
expiration of the Term without renewal, the relationship between the parties will be at will but all other provisions of this Agreement
shall be applicable. This agreement may be terminated by either Employee or Company for cause or willful or gross negligence by
either party. The Board of Directors of the Company may at any time remove the Employee from his position of Vice President of
Global Business Development, which removal shall not be deemed a termination of the Agreement.

 

4.2     Employee’s obligations, and those
of Employee’s employees, agents, successors and assignees, if any pursuant to Section 3 (Confidentiality; Ownership of Documents,
Non-Compete), 5 (Indemnification), and 8 (Governing Law and Dispute Resolution) shall survive completion of Services, and the expiration
or termination of this Agreement.

 

    	 	- 3 -	 

     

    

 

		5.	REPRESENTATION and WARRANTIES; INDEMNIFICATION

 

5.1    The Employee warrants and represents that
he is duly qualified to perform his duties hereunder, and further covenants that in performing his duties hereunder, he will not
engage in activity that is in violation of applicable laws or subject the Company to liability thereunder. The Employee further
warrants that his execution of this Agreement and the performance of services hereunder does not violate any agreement to which
Employee is a party nor give any prior employer, partner, associate or any other person any legal or equitable rights against the
Employee or the Company.

 

5.2        This
Agreement is conditional on the Company’s commitment to obtain a directors’ and officers’ insurance policy as
soon as commercially reasonable, and the Company signing an Indemnification Agreement satisfactory to the Employee. To the fullest
extent permitted by applicable law, the Company agrees that it will not voluntarily change the terms of such D&O Insurance
or the Indemnification Provisions to the detriment of the Employee at anytime while he is entitled to benefit of such D&O Insurance
or Indemnification Provisions. Additionally, the Employee shall be entitled to such indemnification by the Company as is prescribed
in the laws of the State of Florida or in the Charter or Bylaws of the Company.

 

		6.	NOTICES

 

Any notices delivered or received between either
party shall be deemed to have been received:

 

(a)       if it was delivered in person, on the date
it was delivered;

 

(b)       if it was sent by electronic facsimile transmission,
on the date it was delivered;

 

(c)       if it was sent by registered mail, on the
day it was received to the following address:

 

Avra Medical Robotics Inc.

3259 Progress Drive, Suite 126, Orlando, FL
32826

 

By
email: bcohen@avramedical.com

Attention: Barry F. Cohen, CEO

By Facsimile: 407-849-2719

 

Christian Schauer

6455 N 39th Street, Augusta, Michigan 49012

 

By
email: acschauer@comcast.net

 

    	 	- 4 -	 

     

    

 

		7.	MODIFICATION OF AGREEMENT

 

Any modification of this Agreement must be made
in writing and signed by the Employee and the Company, or it shall have no effect and shall be void.

 

		8.	GOVERNING LAW

 

8.1 This Agreement shall be governed by and
construed in accordance with the laws of the State of Florida, without giving effect to any conflict of law rules otherwise.

 

8.2 Any and all disputes
arising hereunder, including disputes arising from or relating to termination and the grounds therefor, including all grounds arising
from statutory claims alleging discrimination or violations of federal, state or local civil rights law, or otherwise, shall be
resolved by binding arbitration in Florida before a single arbitrator in accordance with the arbitration rules of the American
Arbitration Association (the “AAA”) applicable to arbitration then in effect. Notice of the demand for arbitration
by either party shall be given in writing to the other party to this Agreement. On such demand, the dispute shall be heard by arbitration
before a single arbitrator selected pursuant to the AAA rules. Any award rendered by the arbitrator shall be conclusive and binding
on the parties hereto; provided, however, that any such award shall be accompanied by a written opinion of the arbitrator giving
the reasons for the award. The arbitrator shall be entitled to award equitable relief. Each party shall pay its own expenses of
arbitration, including attorneys’ fees. Nothing herein shall prevent the Company from seeking and obtaining preliminary equitable
relief from a court pursuant to Section 3.5.

 

8.3 The parties hereby
submit to the jurisdiction of the federal and state courts located in Florida for the purpose of an order to compel arbitration,
for preliminary relief in aid of arbitration or for a preliminary injunction to maintain the status quo or prevent irreparable
harm prior to the appointment of the arbitrators, and to the non-exclusive jurisdiction of the aforementioned courts for the enforcement
of any award issued hereunder, and waive any right to stay or dismiss any such actions or proceedings brought before any such court
on the basis of forum non conveniens or improper venue.

 

		9.	HEADINGS

 

The headings utilized in
this Agreement are for convenience only and are not to be construed in any way as additions or limitations of the covenants and
agreements contained in this Agreement.

 

		10.	GENERAL MATTERS

 

10.1 The waiver by any party hereto of a breach
of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach of the same or of any
other provisions of this Agreement.

 

    	 	- 5 -	 

     

    

 

10.2       This Agreement shall be binding upon the
parties hereto and shall enure to the benefit of and be enforceable by each of the parties hereto and their respective successors
and assigns, except that the duties and responsibilities of Employee hereunder are of a personal nature and shall not be assignable
or delegable in whole or in part by the Employee without prior written consent of the Company.

 

IN WITNESS WHEREOF the parties hereto have
executed this Agreement as of the 1st day of August 2016.

 

Avra Medical Robotics Inc.,

 

	By:	/s/
    Barry F. Cohen	 
	Name: Barry
    F. Cohen 	 
	Title: CEO	 

 

	/s/
    Albert Christian Schauer	 
	Albert
    Christian Schauer	 

 

    	 	- 6 -	 

     

    

 

SCHEDULE "A"

 

REMUNERATION 

 

		·	As full consideration for performance
of the services by the Employee, the Company shall (i) pay the Employee a base salary of $9,000 (nine thousand dollars) monthly,
beginning with the August 2016 payment, which rate shall be inclusive of all claims by the Employee for his services. However,
Employee agrees to accrue his salary from the Effective Date through and including December 2016 and allows the Board of Directors
to decide on whether to convert any or all accrued salary into Company restricted common shares. Beginning on the Effective Date,
normal direct business expenses will be covered, including business class travel on flights over 5 hours. 

 

		·	Bonus to be as determined by the Board
of Directors with the following factors applying equally: achievement of company goals and plans, capital raising, hiring of key
employees in key locations. Bonus can be paid out quarterly if approved by the Board of Directors. 

 

		·	Employee will also be granted an option
pursuant to the Company’s Equity Incentive Plan (the “Plan”) to purchase 210,000 (two hundred ten thousand) restricted
shares of the Company’s common stock, with an exercise price of $0.10 per share, and a Start Date of Aug 15, 2016. 70,000
shares will be fully vested on each yearly anniversary. Any non-vested options shall be surrendered and cancelled if this Agreement
is terminated. 

 

*      *      *      *      *

 

    	 	- 7 -Exhibit 10.6

 

 

AVRA Medical Robotics, Inc.

3259 Progress Drive, Suite 126, Orlando, FL
32826

 

NON-EXECUTIVE DIRECTOR 

LETTER OF APPOINTMENT

 

	 	 
	 	 
	 	 
	USA	 

 

_________________, 201_

 

Dear _________,

 

I am writing to confirm the terms of your appointment
as non-executive director of AVRA Medical Robotics, Inc., a Florida corporation ("the Company"), which will be ratified
by the board of directors of the Company (“the Board”) no later than at the next board meeting of the Company (“the
Effective Date”).

 

		1.	Appointment

 

You will hold your membership on the Board
in accordance with the Florida Business Corporation Act (the “FBCA”) and the Company's Bylaws as amended from time
to time ("the Bylaws"). Nothing in this letter shall be taken to exclude or vary the terms of the FBCA or the Bylaws
as they apply to you as a director of the Company.

 

		2.	The Company’s obligations to you

 

The
Board will take all reasonable efforts to provide accurate information to enable you to carry out your duties. Such information
will be provided to you in a clear, well-presented and timely manner, validated, if required, by the executive officers as to reliability
and accuracy. The Board will also make best efforts to procure for you within a reasonable time-scale any information about the
business of the Company that you specifically and reasonably request from time to time in order to enable you to carry out your
duties.

 

		3.	Your duties

 

		3.1	As a non-executive director, you have the same general
legal responsibilities to the Company as any other director.

 

		3.2	Other duties, in accordance with the Bylaws, include:

 

		3.2.1	We will expect you to attend Board meetings at a location
(and in such manner, for example, by telephone) on dates subject to reasonable notice, unless prevented by illness or other good
cause. Further meetings may be required if the Company is engaged in acquisitions, investments or other corporate transactions.
In addition to meetings of the Board, you will also be required to attend the Annual Meeting of the Shareholders of the Company
unless your absence has been authorised by the Board. In addition, you will of course be expected to devote such time as is appropriate
to prepare ahead of each meeting.

 

    		 	A- 1 -

     

    

  

 

 

		3.2.3	You may be required and agree in advance to serve on one
or more of the Board's committees, or sub-committees when formed, as the Board may decide and in particular upon the Audit and/or
Compensation Committee.

 

		3.2.4	In addition to your duties above, you may also be asked
to attend other functions, meetings or events relating to the Company from time to time and, subject to your availability you
may from time to time be consulted by other directors on matters to which your experience, knowledge or skills are of relevance.

 

		3.3	You will undertake your duties to the best of your skill
and ability and will discharge your responsibilities as non-executive director of the Company in good faith and in the interests
of the Company.

 

		3.4	You will devote such time and attention as is necessary
for the proper discharge of your responsibilities as non-executive director.

 

		3.5	By accepting this appointment, you confirm that you are
able to allocate sufficient time to meet the expectations of this role. The prior consent of the Board should be obtained before
accepting any commitments that might affect, or conflict with, your role as non-executive director of the Company.

 

		3.6	You will have no authority to commit the Company or to
enter into any legally binding obligation on behalf of the Company or to exercise any powers of the Company.

 

		4.	Other obligations on you

 

		4.1	You will provide all necessary information to enable the
Company to comply with its reporting requirements under the Securities Act of 1933 and/or the Securities Exchange Act of 1934
and comply with requirements expected to be undertaken by a director to a company.

 

		4.2	You will comply with the Company’s rules relating
to share dealings by directors and their families and procure compliance, so far as you are able, by your spouse and any other
persons affected.

 

		4.3	You are generally reminded
of your obligations and responsibilities as a director upon the admission of the Company’s ordinary shares in
the capital of the Company (“Shares”) to trading on the particular market where the shares are being traded from time
to time (“Market”). Consequently, you should avoid making any statements that might risk a breach of these requirements.

 

    		 	A- 2 -

     

    

  

 

 

		5.	Fees and Expenses

 

		5.1	In consideration of the performance of your duties outlined
above, you will be entitled to a director’s fee that will be determined by the Board within a reasonable time after the
Company has raised and received financing in amount equal to a cumulative $2,000,000. Directors’ fees will be reviewed periodically
by the Board.

 

		5.2	In addition,
you will be granted an option pursuant to the Company’s Equity Incentive Plan (the “Plan”) to
purchase _________________ (____________) common shares (the “Shares”) with an exercise price of $___ per share that
will vest as follows: ___________ (__________) shares immediately as of the Effective Date, and the balance of __________ (________)
shares, pro rata, on a monthly basis, as of the first of each month thereafter, over a three-year period. Specifically, as long
as you are a Director in good standing of the Company, you will be vested _______ shares per month. These share numbers will be
adjusted to reflect any stock splits.

 

		5.3	The Company will also reimburse you for all reasonable
and properly documented expenses you incur in performing the duties of your office including travelling expenses necessarily incurred
by you to attend Board meetings. Expenses should be claimed monthly in writing.

 

		5.4	On termination of the appointment for any reason, you will not be entitled to any compensation
for loss of office.

 

		6.	Outside Interests

 

It is understood that you have business interests
other than those of the Company, and indeed, the fact that you do so is of substantial benefit to the Company and enables you to
make a full contribution to the work of the Board by bringing your other experience to bear. In the event that through your other
business interests you become aware of a potential conflict of interest with your position with the Company you should notify the
other directors promptly.

 

    		 	A- 3 -

     

    

  

 

 

		7.	Confidential Information

 

		7.1	During the course of your appointment you may have access
to and become familiar with various secret, proprietary and/or confidential information as set out below (“Confidential
Information and Intellectual Property”). You must not at any time whether before or after the termination of your appointment
with the Company disclose to any person, firm, company or organisation whatsoever nor use, share, print nor publish any secret,
proprietary or confidential information, matter or thing relating to the Company or the business thereof except in the proper
performance of your duties or with the prior written consent of the Board or as required by law. For the purposes of this paragraph,
information shall be secret, proprietary and/or confidential if a reasonable business person would expect that the Company wishes
it to be confidential. Confidential information may relate to or consist of lists or details of customers, details of customers’
contracts, license agreements, customers’ requirements, information relating to any process or invention, engineering developments,
schematics, analysis or research used or produced by the Company and any subsidiary or holding company of the Company or any consultant,
or any third party research provider or other service provider to or on behalf of the Company (“the Group”), information
and knowledge pertaining to business methods, inventions, innovations, designs, ideas, plans, trade secrets, proprietary information,
advertising, sales and profit figures, contact lists, and relationships between the Company and its affiliates, customers, clients,
Employees, licensees, suppliers, and others who have business dealings with the Company or the Group, computer codes (whether
source or object), computer programs or applications, software specifications, user and/or instruction manuals and/or any other
documentation relating to such computer programs or applications, databases of suppliers, customers/clients, employees and target
customers/clients, product lists, service level agreements, price lists, discounts, mark-ups, marketing plans, future business
strategy, tenders, price-sensitive information, staff salary and incentive details, financial management and organisational information
of the Company or any other companies in the Group, any litigation or threatened action involving the Company or any other companies
in the Group, all information in respect of which the Company is bound by an express or implied obligation of confidence to any
third party and any other matter which is notified to you during the course of your appointment as being secret, proprietary or
confidential. This does not apply to any information in the public domain of which you are aware independently of this appointment.

 

    		 	A- 4 -

     

    

  

 

 

		7.2	You shall use the same level of care to prevent any unauthorized use or disclosure of the Confidential
Information and Intellectual Property as you exercise in protecting your own information of a similar nature, but in no event less
than a reasonable standard of care. You shall not, without the prior written consent of the Company, make use of the Confidential
Information disclosed to it for any purpose other than conducting in good faith your duties as director of the Company,
This Section will remain in force for three (3) years following the termination of the Agreement. All documents and other
tangible objects containing or representing Confidential Information or Intellectual Property that have been disclosed by the Company
that are in your possession shall be and remain the property of the Company and shall be promptly returned to the Company upon
request.

 

		8.	Non-Competition during and after Termination/Cessation
of Employment

 

		8.1	The Company may protect its goodwill and trade connections from any unfair competition.

 

		8.2	Throughout the term of this Agreement and for 12 months after termination of your membership on
the Board, you are not permitted to seek business nor solicit any person, firm or company who at any time during the 12 months
immediately preceding the termination has been a customer of the Company, or done business with it and any of the Company’s
employees.

 

    		 	A- 5 -

     

    

  

 

 

		9.	Termination

 

The Company may
terminate your appointment to the Board at any time in accordance with the provisions of the FBCA. All provisions of this letter,
other than the confidentiality provisions of Section 7 and the restrictive covenant in Section 8 hereof, shall terminate simultaneous
with the termination of your Board membership. Upon termination, you will receive a certificate for any shares of the Company’s
common stock that you have earned and vested, and all shares issued to you hereunder that have not vested shall be cancelled.

 

		10.	Professional Advice

 

Occasions may arise when you consider that
you need professional advice in connection with the performance of your duties as a director and you will be able to consult the
Company’s advisers for this purpose. Circumstances may occur when it may be appropriate for you to seek such advice from
independent advisers at the Company’s expense. Such circumstances would be unusual and, if possible, the other directors
should be referred to in the first instance.

 

		11.	Representation and Warranties: Indemnification

 

		11.1	You warrant and represent that you are duly qualified to
perform the duties hereunder, and further covenant that in performing your duties hereunder, you will not engage in activity that
is in violation of applicable laws or subject the Company to liability thereunder. You further warrant that your execution of
this Agreement and the performance of services hereunder does not violate any agreement to which you are a party nor give any
prior employer, partner, associate or any other person any legal or equitable rights against you or the Company.

 

		11.2	The Company commits to make all reasonable efforts to obtain
a directors’ and officers’ insurance policy as soon as commercially reasonable and the Company further agrees to sign
the Indemnification Agreement in the form of Exhibit A hereto. To the fullest extent permitted by applicable law, the Company
agrees that it will not voluntarily change the terms of such D&O Insurance to your detriment at anytime while you are entitled
to benefit of such D&O Insurance or Indemnification Agreement. Additionally, you shall be entitled to such indemnification
by the Company as is prescribed in the laws of the State of Florida or in the Charter or Bylaws of the Company.

 

		12.	Governing law and jurisdiction

 

This Agreement shall be governed by and construed
in accordance with the laws of the State of Florida.

 

Please sign and return to me the enclosed copy
to acknowledge acceptance of the terms set out herein.

 

Yours sincerely,

 

Barry F. Cohen

For and on behalf of AVRA Medical Robotics,
Inc.

 

I hereby agree to act as non-executive director
of AVRA Medical Robotics, Inc. upon the terms set out in the letter of which this is a copy.

 

	Signed	 	 	Dated	 

 

    		 	A- 6 -

     

    

 

 

 

Role

 

Non-executive directors have the same general
legal responsibilities to the Company as any other director. The Board as a whole is collectively responsible for promoting the
success of the Company by directing and supervising the Company’s affairs.

 

The Board:

 

		·	Provides entrepreneurial leadership of the Company within a framework of prudent and effective
controls which enable risk to be assessed and managed; and

 

		·	Set the Company’s strategic aims, ensures that the necessary financial and human resources
are in place for the Company to meet its objectives, and reviews management performance; and

 

		·	Sets the Company’s values and standards and ensures that its obligations to its shareholders
and others are understood and met.

 

In addition to these requirements of all directors,
the role of a non-executive has the following key elements:

 

		·	Strategy: constructively challenge and contribute to the development of strategy; and

 

		·	Performance: scrutinise the performance of management in meeting agreed goals and objectives
and monitor the reporting of performance; and

 

		·	Risk: satisfy themselves that financial information is accurate and that financial controls
and systems of risk management are robust and defensible; and

 

		·	People: be responsible for determining appropriate levels of remuneration of executive directors,
taking a prime role in appointing, and where necessary, removing senior management and in succession planning.

 

    		 	A- 7 -

     

    

 

 

 

EXHIBIT A

 

INDEMNIFICATION AGREEMENT

 

This Indemnification Agreement
(this “Agreement”), dated as of the ___ day of _________, 201_ is made by and between Avra Medical Robotics
Inc., a Florida corporation (the “Company”), ___________________________, residing at ______________________________________,
USA (hereinafter the “Indemnitee”).

 

RECITALS

 

A.           The
Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers
and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities
to which they may become personally exposed as a result of performing their duties for the Company;

 

B.           The
Company and the Indemnitee are aware of the substantial growth in the number of lawsuits filed against corporate officers and directors
in connection with their activities in such capacities and by reason of their status as such;

 

C.           The
Company and the Indemnitee recognize that the cost of defending against such lawsuits, whether or not meritorious, is typically
beyond the financial resources of most officers and directors of the Company;

 

D.           The
Company and the Indemnitee recognize that the legal risks and potential liabilities, and the threat thereof, associated with proceedings
filed against the officers and directors of the Company bear no reasonable relationship to the amount of compensation received
by the Company’s officers and directors;

 

E.           The
Company, after reasonable investigation prior to the date hereof, has determined that the liability insurance coverage available
to the Company as of the date hereof is inadequate, unreasonably expensive or both. The Company believes, therefore, that the interest
of the Company and its current and future stockholders would be best served by a combination of (i) such insurance as the Company
may obtain pursuant to the Company’s obligations hereunder and (ii) a contract with its officers and directors, including
the Indemnitee, to indemnify them to the fullest extent permitted by law (as in effect on the date hereof, or, to the extent any
amendment may expand such permitted indemnification, as hereafter in effect) against personal liability for actions taken in the
performance of their duties to the Company;

 

F.           Section
607.0850 of the Florida Business Corporation Act empowers Florida corporations to indemnify their officers and directors and further
states that the indemnification provided by Section 607.0850 shall not be deemed exclusive of any other rights to which those seeking
indemnification may be entitled under the articles of incorporation or any bylaw, agreement, vote of stockholders or disinterested
directors or otherwise, both as to action in an official capacity and as to action in another capacity while holding such office;
thus, Section 607.0850 does not by itself limit the extent to which the Company may indemnify persons serving as its officers and
directors;

 

    	 	 	1

     

    

 

 

 

G.           The
Company’s Articles of Incorporation and Bylaws authorize the indemnification of the officers and directors of the Company
in excess of that expressly permitted by Section 607.0850;

 

H.           The
Board of Directors of the Company has concluded that, to retain and attract talented and experienced individuals to serve as officers
and directors of the Company and to encourage such individuals to take the business risks necessary for the success of the Company,
it is necessary for the Company to contractually indemnify its officers and directors, and to assume for itself liability for expenses
and damages in connection with claims against such officers and directors in connection with their service to the Company, and
has further concluded that the failure to provide such contractual indemnification could result in great harm to the Company and
its stockholders;

 

I.           The
Company desires and has requested the Indemnitee to serve or continue to serve as a director or officer of the Company, free from
undue concern for the risks and potential liabilities associated with such services to the Company; and

 

J.           The
Indemnitee is willing to serve, or continue to serve, the Company, provided, and on the expressed condition, that the Indemnitee
is furnished with the indemnification provided for herein.

 

AGREEMENT

 

NOW, THEREFORE, the Company
and Indemnitee agree as follows:

 

1.          DEFINITIONS.

 

(a)          “EXPENSES”
means, for the purposes of this Agreement, all direct and indirect costs of any type or nature whatsoever (including, without limitation,
any fees and disbursements of Indemnitee’s counsel, accountants and other experts and other out-of-pocket costs) actually
and reasonably incurred by the Indemnitee in connection with the investigation, preparation, defense or appeal of a Proceeding;
provided, however, that Expenses shall not include judgments, fines, penalties or amounts paid in settlement of a Proceeding.

 

(b)          “PROCEEDING”
means, for the purposes of this Agreement, any threatened, pending or completed action or proceeding, whether civil, criminal,
administrative or investigative (including an action brought by or in the right of the Company) in which Indemnitee may be or may
have been involved as a party or otherwise, by reason of the fact that Indemnitee is or was a director or officer of the Company,
by reason of any action taken by Indemnitee or of any inaction on his or her part while acting as such director or officer or by
reason of the fact that he or she is or was serving at the request of the Company as a director, officer, employee or agent of
another foreign or domestic corporation, partnership, joint venture, trust or other enterprise, or was a director or officer of
the foreign or domestic corporation which was a predecessor corporation to the Company or of another enterprise at the request
of such predecessor corporation, whether or not he or she is serving in such capacity at the time any liability or expense is incurred
for which indemnification or reimbursement can be provided under this Agreement.

 

    	 	 	2

     

    

  

 

 

2.          AGREEMENT
TO SERVE. Indemnitee agrees to serve or continue to serve as a director or officer of the Company to the best of his or her
abilities at the will of the Company or under separate contract, if such contract exists, for so long as Indemnitee is duly elected
or appointed and qualified or until such time as the Indemnitee tenders his or her resignation in writing. Nothing contained in
this Agreement is intended to create in Indemnitee any right to continued employment.

 

3.          INDEMNIFICATION.

 

(a)          THIRD
PARTY PROCEEDINGS. The Company shall indemnify Indemnitee against Expenses, judgments, fines, penalties or amounts paid in settlement
(if the settlement is approved in advance by the Company) actually and reasonably incurred by Indemnitee in connection with a Proceeding
(other than a Proceeding by or in the right of the Company) if Indemnitee acted in good faith and in a manner Indemnitee reasonably
believed to be in the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable
cause to believe Indemnitee’s conduct was unlawful. The termination of any Proceeding by judgment, order, settlement, conviction,
or upon a plea of NOLO CONTENDERE or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in
good faith and in a manner which Indemnitee reasonably believed to be in the best interests of the Company, or, with respect to
any criminal Proceeding, had no reasonable cause to believe that Indemnitee's conduct was unlawful.

 

(b)          PROCEEDINGS
BY OR IN THE RIGHT OF THE COMPANY. To the fullest extent permitted by law, the Company shall indemnify Indemnitee against Expenses
and amounts paid in settlement, actually and reasonably incurred by Indemnitee in connection with a Proceeding by or in the right
of the Company to procure a judgment in its favor if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed
to be in the best interests of the Company and its stockholders. Notwithstanding the foregoing, no indemnification shall be made
in respect of any claim, issue or matter as to which Indemnitee shall have been adjudged liable to the Company in the performance
of Indemnitee’s duty to the Company and its stockholders unless and only to the extent that the court in which such action
or Proceeding is or was pending shall determine upon application that, in view of all the circumstances of the case, Indemnitee
is fairly and reasonably entitled to indemnity for Expenses and then only to the extent that the court shall determine.

 

(c)          SCOPE.
Notwithstanding any other provision of this Agreement but subject to Section 3(b) and Section 14(b), the Company shall indemnify
the Indemnitee to the fullest extent permitted by law, notwithstanding that such indemnification is not specifically authorized
by other provisions of this Agreement, the Company’s Articles of Incorporation, the Company’s Bylaws or by statute.

 

4.          LIMITATIONS
ON INDEMNIFICATION. Any other provision herein to the contrary notwithstanding, the Company shall not be obligated pursuant to
the terms of this Agreement:

 

(a)          EXCLUDED
ACTS. To indemnify Indemnitee for any acts or omissions or transactions from which a director may not be relieved of liability
under applicable law;

 

(b)          EXCLUDED
INDEMNIFICATION PAYMENTS. To indemnify or advance Expenses in violation of any prohibition or limitation on indemnification under
the statutes, regulations or rules promulgated by any state or federal regulatory agency having jurisdiction over the Company;

 

    	 	 	3

     

    

  

 

 

(c)          CLAIMS
INITIATED BY INDEMNITEE. To indemnify or advance Expenses to Indemnitee with respect to Proceedings or claims initiated or brought
voluntarily by Indemnitee and not by way of defense, except with respect to Proceedings brought to establish or enforce a right
to indemnification under this Agreement or any other statute or law or otherwise as required under Section 607.0850 of the Florida
Business Corporation Act, but such indemnification or advancement of Expenses may be provided by the Company in specific cases
if the Board of Directors has approved the initiation or bringing of such suit;

 

(d)          LACK
OF GOOD FAITH. To indemnify Indemnitee for any Expenses incurred by the Indemnitee with respect to any Proceeding instituted by
Indemnitee to enforce or interpret this Agreement, if a court of competent jurisdiction determines that each of the material assertions
made by the Indemnitee in such Proceeding was not made in good faith or was frivolous;

 

(e)          INSURED
CLAIMS. To indemnify Indemnitee for Expenses or liabilities of any type whatsoever (including, but not limited to, judgments, fines,
ERISA excise taxes or penalties, and amounts paid in settlement) which have been paid directly to or on behalf of Indemnitee by
an insurance carrier under a policy of directors’ and officers’ liability insurance maintained by the Company or any
other policy of insurance maintained by the Company or Indemnitee; or

 

(f)          CLAIMS
UNDER SECTION 16(b). To indemnify Indemnitee for Expenses and the payment of profits arising from the purchase and sale by Indemnitee
of securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute.

 

5.          DETERMINATION
OF RIGHT TO INDEMNIFICATION. Upon receipt of a written claim addressed to the Board of Directors for indemnification pursuant to
Section 3, the Company shall determine by any of the methods set forth in Section 607.0850 of the Florida Business Corporation
Act whether Indemnitee has met the applicable standards of conduct which makes it permissible under applicable law to indemnify
Indemnitee. If such standards have been met and a claim under Section 3 is not paid in full by the Company within ninety (90) days
after such written claim has been received by the Company, the Indemnitee may at any time thereafter bring suit against the Company
to recover the unpaid amount of the claim and, unless such action is dismissed by the court as frivolous or brought in bad faith,
the Indemnitee shall be entitled to be paid also the expense of prosecuting such claim. The court in which such action is brought
shall determine whether Indemnitee or the Company shall have the burden of proof concerning whether Indemnitee has or has not met
the applicable standard of conduct.

 

6.          ADVANCEMENT
AND REPAYMENT OF EXPENSES. Subject to Section 4 hereof, the Expenses incurred by Indemnitee in defending and investigating any
Proceeding shall be paid by the Company in advance of the final disposition of such Proceeding within 30 days after receiving from
Indemnitee the copies of invoices presented to Indemnitee for such Expenses, if Indemnitee shall provide an undertaking to the
Company to repay such amount to the extent it is ultimately determined that Indemnitee is not entitled to indemnification. In determining
whether or not to make an advance hereunder, the ability of Indemnitee to repay shall not be a factor. Notwithstanding the foregoing,
in a proceeding brought by the Company directly, in its own right (as distinguished from an action bought derivatively or by any
receiver or trustee), the Company shall not be required to make the advances called for hereby if the Board of Directors determines,
in its sole discretion, that it does not appear that Indemnitee has met the standards of conduct which make it permissible under
applicable law to indemnify Indemnitee and the advancement of Expenses would not be in the best interests of the Company and its
stockholders.

 

    	 	 	4

     

    

  

 

 

7.          PARTIAL
INDEMNIFICATION. If the Indemnitee is entitled under any provision of this Agreement to indemnification or advancement by the Company
of some or a portion of any Expenses or liabilities of any type whatsoever (including, but not limited to, judgments, fines, penalties,
and amounts paid in settlement) incurred by him in the investigation, defense, settlement or appeal of a Proceeding, but is not
entitled to indemnification or advancement of the total amount thereof, the Company shall nevertheless indemnify or pay advancements
to the Indemnitee for the portion of such Expenses or liabilities to which the Indemnitee is entitled.

 

8.          NOTICE
TO COMPANY BY INDEMNITEE. Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends
to seek indemnification hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof;
provided, however, that any delay in so notifying the Company shall not constitute a waiver by Indemnitee of her rights hereunder.
The written notification to the Company shall be addressed to the Board of Directors and shall include a description of the nature
of the Proceeding and the facts underlying the Proceeding and be accompanied by copies of any documents filed with the court in
which the Proceeding is pending. In addition, Indemnitee shall give the Company such information and cooperation as it may reasonably
require and as shall be within Indemnitee’s power.

 

9.          MAINTENANCE
OF LIABILITY INSURANCE.

 

(a)          Subject
to Section 4 hereof, the Company hereby agrees that so long as Indemnitee shall continue to serve as a director or officer of the
Company and thereafter so long as Indemnitee shall be subject to any possible Proceeding, the Company, subject to Section 9(b),
shall use reasonable commercial efforts to obtain and maintain in full force and effect directors’ and officers’ liability
insurance (“D&O Insurance”) which provides Indemnitee the same rights and benefits as are accorded to the
most favorably insured of the Company’ directors, if Indemnitee is a director; or of the Company’s officers, if Indemnitee
is not a director of the Company but is an officer.

 

(b)          Notwithstanding
the foregoing, the Company shall have no obligation to obtain or maintain D&O Insurance if the Company determines in good faith
that such insurance is not reasonably available, the premium costs for such insurance are disproportionate to the amount of coverage
provided, the coverage provided by such insurance is limited by exclusions so as to provide an insufficient benefit, or the Indemnitee
is covered by similar insurance maintained by a subsidiary or parent of the Company.

 

(c)          If,
at the time of the receipt of a notice of a claim pursuant to Section 8 hereof, the Company has D&O Insurance in effect, the
Company shall give prompt notice of the commencement of such Proceeding to the insurers in accordance with the procedures set forth
in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay,
on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.

 

    	 	 	5

     

    

  

 

 

10.         DEFENSE
OF CLAIM. In the event that the Company shall be obligated under Section 6 hereof to pay the Expenses of any Proceeding against
Indemnitee, the Company, if appropriate, shall be entitled to assume the defense of such Proceeding, with counsel approved by Indemnitee,
which approval shall not be unreasonably withheld, upon the delivery to Indemnitee of written notice of its election to do so.
After delivery of such notice, approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company
will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect
to the same Proceeding, provided that (i) Indemnitee shall have the right to employ counsel in any such Proceeding at Indemnitee’s
expense; and (ii) if (A) the employment of counsel by Indemnitee has been previously authorized by the Company, or (B) Indemnitee
shall have reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee in the conduct
of such defense or (C) the Company shall not, in fact, have employed counsel to assume the defense of such Proceeding, then the
fees and expenses of Indemnitee’s counsel shall be at the expense of the Company.

 

11.         ATTORNEYS’
FEES. In the event that Indemnitee or the Company institutes an action to enforce or interpret any terms of this Agreement, the
Company shall reimburse Indemnitee for all of the Indemnitee’s reasonable fees and expenses in bringing and pursuing such
action or defense, unless as part of such action or defense, a court of competent jurisdiction determines that the material assertions
made by Indemnitee as a basis for such action or defense were not made in good faith or were frivolous.

 

12.         CONTINUATION
OF OBLIGATIONS. All agreements and obligations of the Company contained herein shall continue during the period the Indemnitee
is a director or officer of the Company, or is or was serving at the request of the Company as a director, officer, fiduciary,
employee or agent of another corporation, partnership, joint venture, trust or other enterprise, and shall continue thereafter
so long as the Indemnitee shall be subject to any possible proceeding by reason of the fact that Indemnitee served in any capacity
referred to herein.

 

13.         SUCCESSORS
AND ASSIGNS. This Agreement establishes contract rights that shall be binding upon, and shall inure to the benefit of, the successors,
assigns, heirs and legal representatives of the parties hereto.

 

14.         NON-EXCLUSIVITY.

 

(a)          The
provisions for indemnification and advancement of expenses set forth in this Agreement shall not be deemed to be exclusive of any
other rights that the Indemnitee may have under any provision of law, the Company’s Articles of Incorporation or Bylaws,
the vote of the Company’s stockholders or disinterested directors, other agreements or otherwise, both as to action in the
Indemnitee’s official capacity and action in another capacity while occupying the Indemnitee’s position as a director
or officer of the Company.

 

(b)          In
the event of any changes, after the date of this Agreement, in any applicable law, statute, or rule which expand the right of a
Florida corporation to indemnify its officers and directors, the Indemnitee’s rights and the Company’s obligations
under this Agreement shall be expanded to the full extent permitted by such changes. In the event of any changes in any applicable
law, statute or rule, which narrow the right of a Florida corporation to indemnify a director or officer, such changes, to the
extent not otherwise required by such law, statute or rule to be applied to this Agreement, shall have no effect on this Agreement
or the parties’ rights and obligations hereunder.

 

    	 	 	6

     

    

  

 

 

15.         EFFECTIVENESS
OF AGREEMENT. To the extent that the indemnification permitted under the terms of certain provisions of this Agreement exceeds
the scope of the indemnification provided for in the Florida Statutes, such provisions shall not be effective unless and until
the Company’s Articles of Incorporation authorize such additional rights of indemnification. In all other respects, the balance
of this Agreement shall be effective as of the date set forth on the first page and may apply to acts of omissions of Indemnitee
which occurred prior to such date if Indemnitee was an officer, director, employee or other agent of the Company, or was serving
at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust
or other enterprise, at the time such act or omission occurred.

 

16.         SEVERABILITY.
Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to do any act in
violation of applicable law. The Company’s inability, pursuant to court order, to perform its obligations under this Agreement
shall not constitute a breach of this Agreement. The provisions of this Agreement shall be severable as provided in this Section
16. If this Agreement or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the
Company shall nevertheless indemnify Indemnitee to the full extent permitted by any applicable portion of this Agreement that shall
not have been invalidated, and the balance of this Agreement not so invalidated shall be enforceable in accordance with its terms.

 

17.         GOVERNING LAW. This
Agreement shall be interpreted and enforced in accordance with the laws of the State of Florida, without reference to its conflict
of law principals. To the extent permitted by applicable law, the parties hereby waive any provisions of law which render any provision
of this Agreement unenforceable in any respect.

 

18.         NOTICE.
All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given
(i) if delivered by hand and receipted for by the party addressee or (ii) if mailed by certified or registered mail with postage
prepaid, on the third business day after the mailing date. Addresses for notice to either party are as shown on the signature page
of this Agreement, or as subsequently modified by written notice.

 

19.         MUTUAL
ACKNOWLEDGMENT. Both the Company and Indemnitee acknowledge that in certain instances, federal law or applicable public policy
may prohibit the Company from indemnifying its directors and officers under this Agreement or otherwise. Indemnitee understands
and acknowledges that the Company has undertaken or may be required in the future to undertake with the appropriate state or federal
regulatory agency to submit for approval any request for indemnification, and has undertaken or may be required in the future to
undertake with the Securities and Exchange Commission to submit the question of indemnification to a court in certain circumstances
for a determination of the Company’s right under public policy to indemnify Indemnitee.

 

20.         COUNTERPARTS.
This Agreement may be executed in one or more counterparts, each of which shall constitute an original.

 

21.         AMENDMENT
AND TERMINATION. No amendment, modification, termination or cancellation of this Agreement shall be effective unless in writing
signed by both parties hereto.

 

[Signature Page Follows]

 

    	 	 	7

     

    

  

 

 

IN WITNESS WHEREOF, the
parties have executed this Agreement as of the day and year set forth above.

 

	 	AVRA MEDICAL ROBOTICS INC.
	 	 	 
	 	BY:	 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	INDEMNITEE
	 	 
	 	 
	 	Name:	 
	 	 	 
	 	Address:	 

 

    	 	 	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]